Product Information
LUTERA-28 TABLET is a generic product labeled by Mayne Pharma, priced at $0.1518 per EA under NDC 51862002806. Its NADAC has been published 477 times since Mar 15, 2017.
FDA first approved this application on Nov 18, 2004. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Mayne PharmaNDC
51862002806
Classification
Generic
Dosage Form
KIT
Effective Date
4/22/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA076625FDA Approved
11/18/2004
TE Code
AB1
On Market Since
8/3/2016
Price Statistics
The NADAC for LUTERA-28 TABLET has been published 477 times since Mar 15, 2017, and over the history we have for it it has declined 66.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1518 per EA |
|---|---|
| All-time high | $0.4664 (Sep 13, 2017) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1518 |
| Median price | $0.2232 |
| Average price | $0.2435 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 477 |
| Tracking since | Mar 15, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
-2.9%
1Y
-3.2%
3Y
-15.3%
5Y
-33.3%
All
-66.9%
Last surveyed Apr 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LUTERA-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LUTERA-28 TABLET, manufactured by Mayne Pharma, is $0.1518 per EA (NDC 51862002806), effective Apr 29, 2026.
How has the price of LUTERA-28 TABLET changed over time?
Over the history we have for it, the NADAC for LUTERA-28 TABLET has declined 66.9%. It has been tracked across 477 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for LUTERA-28 TABLET?
Since Mar 15, 2017, the NADAC for LUTERA-28 TABLET has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.4664 (Sep 13, 2017), with a median of $0.2232 per EA.
Are there cheaper alternatives to LUTERA-28 TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVONOR-ETH ESTRAD 0.15-0.03, is $0.1128 per EA — about 26% below LUTERA-28 TABLET.
Who manufactures LUTERA-28 TABLET?
LUTERA-28 TABLET (NDC 51862002806) is labeled by Mayne Pharma, and CMS classifies it as a generic product.